Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015 Mar:147:81-4.
doi: 10.1016/j.jsbmb.2014.11.002. Epub 2014 Nov 6.

Membrane-mediated actions of 1,25-dihydroxy vitamin D3: a review of the roles of phospholipase A2 activating protein and Ca(2+)/calmodulin-dependent protein kinase II

Affiliations
Review

Membrane-mediated actions of 1,25-dihydroxy vitamin D3: a review of the roles of phospholipase A2 activating protein and Ca(2+)/calmodulin-dependent protein kinase II

Maryam Doroudi et al. J Steroid Biochem Mol Biol. 2015 Mar.

Abstract

The secosteroid 1α,25-dihydroxy vitamin D3 [1α,25(OH)2D3] acts on cells via classical steroid hormone receptor-mediated gene transcription and by initiating rapid membrane-mediated signaling pathways. In its membrane-initiated pathway, after 1α,25(OH)2D3 interacts with protein disulfide isomerase, family A, member 3 (Pdia3) in caveolae, phospholipase A2 (PLA2) and protein kinase C (PKC) are activated. Recent efforts to determine the signaling proteins involved in the 1α,25(OH)2D3 signal from Pdia3 to PLA2 have indicated that phospholipase A2 activating protein (PLAA) and Ca(2+)/calmodulin-dependent kinase II (CaMKII) are required. PLAA is located in caveolae, where it interacts with Pdia3 and caveolin-1 (Cav-1) to initiate rapid signaling via CaMKII, activating PLA2, leading to activation of protein kinase C (PKC) and PKC-dependent responses.

Keywords: 1α,25(OH)(2)D(3); Ca(2+)/calmodulin-dependent protein kinase II; PDIA3; PLA(2); PLAA; Protein kinase C.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Effects of Pdia3, Vdr and Cav-1 silencing on 1α,25(OH)2D3-stimulated PKC activation in MC3T3-E1 osteoblasts. The data show treatment vs. vehicle ratios. *p<0.05, vs. vehicle; $p<0.05, vs. 1α,25(OH)2D3 treated WT.
Figure 2
Figure 2
Effects of Plaa silencing on CaMKII, PLA2 and PKC activation, and PGE2 release in MC3T3-E1 osteoblast in response to 1α,25(OH)2D3. The data show treatment vs. vehicle ratios. The dashed line represents the vehicle control (dashed line=1). *p<0.05, treatment vs. control; #p<0.05, WT vs. ShPlaa.
Figure 3
Figure 3
Effects of Camk2a silencing on CaMKII, PLA2 and PKC activation, and PGE2 release in MC3T3-E1 osteoblast cells. The data show treatment vs. vehicle ratios. The dashed line represents the vehicle control (dashed line=1). *p<0.05, treatment vs. control; #p<0.05, WT vs. ShCamk2a.
Figure 4
Figure 4
Overview of 1α,25(OH)2D3 membrane-mediated pathway.

References

    1. Panda DK, Miao D, Tremblay ML, Sirois J, Farookhi R, Hendy GN, Goltzman D. Targeted ablation of the 25-hydroxyvitamin D 1alpha-hydroxylase enzyme: evidence for skeletal, reproductive, and immune dysfunction. Proc Natl Acad Sci U S A. 2001;98:7498–7503. - PMC - PubMed
    1. Li YC, Pirro AE, Amling M, Delling G, Baron R, Bronson R, Demay MB. Targeted ablation of the vitamin D receptor: an animal model of vitamin D-dependent rickets type II with alopecia. Proc Natl Acad Sci U S A. 1997;94:9831–9835. - PMC - PubMed
    1. van Leeuwen JP, van Driel M, van den Bemd GJ, Pols HA. Vitamin D control of osteoblast function and bone extracellular matrix mineralization. Crit Rev Eukaryot Gene Expr. 2001;11:199–226. - PubMed
    1. van Driel M, Pols HA, van Leeuwen JP. Osteoblast differentiation and control by vitamin D and vitamin D metabolites. Curr Pharm Des. 2004;10:2535–2555. - PubMed
    1. Hendy GN, Hruska KA, Mathew S, Goltzman D. New insights into mineral and skeletal regulation by active forms of vitamin D. Kidney Int. 2006;69:218–223. - PubMed

Publication types

MeSH terms

LinkOut - more resources